View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Edwards Lifesciences Corp: 3 directors

Three Directors at Edwards Lifesciences Corp sold/sold after exercising options/gave away 22,120 shares at between 0.000USD and 84.029USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretion...

Andy Hanson ... (+2)
  • Andy Hanson
  • Carl Smith

boohoo Group (DEBS LN) - Interim results – Marketplace transformation ...

Two years of transition can clearly be seen in Debenhams interim results with 30% of revenue now derived from marketplace. This asset light, cost light, high margin, cash generative model is a game changer in terms of the longer-term valuation. Whilst there is further work to be done, we see strong potential for the Group to deliver sustainable, profitable growth via its proprietary marketplace platform. Based on our forecasts, the shares trade on only 6.4x FY26 EV/EBITDA, falling to 5.2x in FY2...

Andy Hanson ... (+3)
  • Andy Hanson
  • Charlie Williams
  • Rachel Birkett

boohoo Group (DEBS LN) - FY25 results: Executing on turnaround - Corpo...

boohoo Group has released FY25 results to February year end showing significant progress against its multi-year strategy of turning the Group into a capital-lite, stock-lite, cost-lite, cash generative marketplace model. Group revenue and EBITDA were broadly in line with Zeus’ estimates (page 2), with net debt showing significant improvements since H1-25 of £78.2m vs £143.1m, following the equity raise and disposal of non-core assets. Today’s announcement also confirms the discontinuation of PLT...

Moody's Ratings affirms Edwards Lifesciences at Baa2; revises outlook ...

Moody's Ratings (Moody's) affirmed the ratings of Edwards Lifesciences Corporation (Edwards) including the Baa2 senior unsecured notes and Baa2 senior unsecured bank credit facilities. At the same time, we revised the outlook to positive from stable. The rating affirmation reflects our view that E...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: April 5, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: April 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 28, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 25, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 22, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

STAAR Surgical Announces Realignment of Leadership Structure

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the following changes to right size and realign its leadership structure to better address market needs: Warren Foust, Chief Operating Officer, has been promoted to the newly created role of President and Chief Operating Officer. In this expanded role, Mr. Foust will continue to oversee STAAR’s sales, manufacturing, and operations functions. Under this new leadership structure, the ...

Rachel Birkett
  • Rachel Birkett

boohoo Group (BOO LN) - Debenhams rebrand signals strategic shift to m...

A rebrand to Debenhams Group signals a step change in strategy, with a capital-lite stock-lite and cash generative marketplace model to be adopted across all brands. Debenhams is now the majority contributor to Group profitability having scaled rapidly since its 2021 relaunch (we forecast c.£32m of EBITDA contribution in FY26). Its marketplace operating model and proprietary tech is now the blueprint for a wider group transformation. At Karen Millen trading remains resilient against a tough mar...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 8, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch